Converted Organics Announces PharmaSphere Enters Research Agreement for Medical Marijuana Growth Study
Converted Organics Inc. (Nasdaq: COIN) announced today that PharmaSphere, LLC, a subsidiary of Converted Organics, has commenced a Research Trial with Dr. Andrew Riseman, Associate Professor, Agroecology, Faculty of Land and Food Systems and the Centre for Plant Research, University of British Columbia for the production of cannabis using TerraSphere's controlled environment production systems.
The study will utilize TerraSphere's proprietary vertical farming system and will focus on expanding the cultivation and availability of cannabis for medicinal use. Under the direction of Dr. Riseman, the Trial will develop methods for cannabis production within the controlled environment. Dr. Riseman, in his capacity as an independent consultant, will oversee all aspects of the trial and produce a final report detailing the results, including production parameters, yields and biochemical profiles.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.